These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19190769)

  • 1. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.
    Schettini J; Mukherjee P
    Clin Dev Immunol; 2008; 2008():106321. PubMed ID: 19190769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
    Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
    Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of human plasmacytoid dendritic cells.
    Cao W
    J Clin Immunol; 2009 May; 29(3):257-64. PubMed ID: 19266271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing human plasmacytoid dendritic cells as professional APCs.
    Tel J; van der Leun AM; Figdor CG; Torensma R; de Vries IJ
    Cancer Immunol Immunother; 2012 Aug; 61(8):1279-88. PubMed ID: 22294456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid dendritic cell in immunity and cancer.
    Mitchell D; Chintala S; Dey M
    J Neuroimmunol; 2018 Sep; 322():63-73. PubMed ID: 30049538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dendritic cell-based therapeutic cancer vaccines].
    Rizzo M; Alaniz L; Mazzolini GD
    Medicina (B Aires); 2016; 76(5):307-314. PubMed ID: 27723619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.
    Burdin N; Moingeon P
    Cell Biol Toxicol; 2001; 17(2):67-75. PubMed ID: 11499697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition and Presentation of Tumor Antigens by Dendritic Cells.
    Bonaccorsi I; Campana S; Morandi B; Ferlazzo G
    Crit Rev Immunol; 2015; 35(5):349-64. PubMed ID: 26853848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifaceted biology of plasmacytoid dendritic cells.
    Swiecki M; Colonna M
    Nat Rev Immunol; 2015 Aug; 15(8):471-85. PubMed ID: 26160613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.
    Bencze D; Fekete T; Pázmándi K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy via dendritic cells.
    Palucka K; Banchereau J
    Nat Rev Cancer; 2012 Mar; 12(4):265-77. PubMed ID: 22437871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.
    Demoulin S; Herfs M; Delvenne P; Hubert P
    J Leukoc Biol; 2013 Mar; 93(3):343-52. PubMed ID: 23136258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cell-Based Cancer Vaccines.
    Santos PM; Butterfield LH
    J Immunol; 2018 Jan; 200(2):443-449. PubMed ID: 29311386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
    Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
    J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.